Premium
P4‐073: A PHARMACOGENETICS‐SUPPORTED CLINICAL TRIAL TO DELAY ONSET OF MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE USING LOW‐DOSE PIOGLITAZONE: AN UPDATE ON THE TOMORROW STUDY
Author(s) -
Budur Kumar,
WelshBohmer Kathleen,
Burns Daniel,
Chiang Carl,
O'Neil Janet,
Runyan Grant,
Cyganowski Marcia,
Crenshaw Donna G.,
Lutz Michael W.,
Metz Craig,
Saunders Ann,
Yarbrough Deborah,
Yarnall David,
Lai Eric,
Brannan Stephen,
Roses Allen D.
Publication year - 2014
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2014.05.1588
Subject(s) - pioglitazone , neuropsychology , cognitive decline , clinical endpoint , medicine , placebo , clinical dementia rating , disease , dementia , clinical trial , cognition , psychology , psychiatry , type 2 diabetes , diabetes mellitus , pathology , endocrinology , alternative medicine